Stages of lung adenocarcinoma explained

Doctors combine the primary tumour's size and local invasion with information about nearby lymph nodes and distant spread. The clinical stage is based on examinations and scans; a pathological stage may be assigned after surgery provides tissue for closer assessment.

The TNM framework records the tumour, regional lymph nodes and metastasis. Those findings are combined into an overall stage grouping. Limited disease may remain within the lung or nearby structures, while more advanced disease may involve distant organs. A scan finding alone may need further imaging or a biopsy before the team confirms what it represents.

Stage and tumour biology answer different questions. Stage maps where cancer is found; genomic tumour profiling examines selected molecular features. Both can affect the plan, so a stage label does not by itself specify one treatment.

Review the scan summary and biopsy result with the oncology team, and ask whether the stage is clinical or pathological. Clarify whether any uncertain area needs another scan, sampling or specialist discussion before treatment starts.

For disease that can be treated locally, an operation or radiotherapy may form a central part of care. Medicines may be offered before or after local treatment, or as the main treatment when cancer is present in several sites. The choice also reflects breathing capacity, other health conditions, tumour markers and your priorities.

Call emergency services for sudden severe breathlessness, chest pain with faintness, a seizure, new one-sided weakness, new confusion, or coughing up a significant amount of blood. Urgency comes from the symptom itself, not from the assigned stage.

Tell your care team soon about a persistent new headache, increasing bone pain, worsening breathlessness, a hoarse voice that is changing, or reduced ability to manage normal activities. New symptoms do not establish a stage change; clinicians assess them and decide whether further tests are appropriate.

Useful questions include: Which TNM findings led to my stage? Is anything still uncertain? Has the case been discussed by a multidisciplinary team? Ask which treatments address the lung tumour, lymph nodes or distant sites, and what would prompt the plan to change.